ORAL LIQUID FORMULATION OF EMPAGLIFLOZIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

The present invention relates to a liquid formulation comprising Empagliflozin or its pharmaceutically acceptable salt with one or more pharmaceutically acceptable excipient, its process for preparation and its application in the treatment of type 2 diabetes mellitus, symptomatic chronic heart failu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MUNDADA, Piyush Kishor, ACHLIYA, Girish Shantilal, FALDU, Dipak Rameshbhai, KAPADIA, Mayur Dilip
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a liquid formulation comprising Empagliflozin or its pharmaceutically acceptable salt with one or more pharmaceutically acceptable excipient, its process for preparation and its application in the treatment of type 2 diabetes mellitus, symptomatic chronic heart failure and chronic kidney disease. La présente invention concerne une formulation liquide comprenant de l'empagliflozine ou son sel pharmaceutiquement acceptable avec un ou plusieurs excipients pharmaceutiquement acceptables, son procédé de préparation et son application dans le traitement du diabète sucré de type 2, de l'insuffisance cardiaque chronique symptomatique et de la maladie rénale chronique.